{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:08:58Z","timestamp":1789823338697,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022720","name":"Health Bureau","doi-asserted-by":"publisher","award":["11220036"],"award-info":[{"award-number":["11220036"]}],"id":[{"id":"10.13039\/100022720","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.adro.2026.102178","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T14:16:21Z","timestamp":1786889781000},"page":"102178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Updated Level IVa Nodal Delineation on Thyroid Dose and Hypothyroidism Risk in Nasopharyngeal Carcinoma"],"prefix":"10.1016","volume":"11","author":[{"given":"Jeffrey C.F.","family":"Lui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor H.F.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis K.H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok Hung","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.W.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5305-4342","authenticated-orcid":false,"given":"James C.H.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2026.102178_bib0001","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2026.102178_bib0002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2407-12-98","article-title":"Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: A meta-analysis of clinical evidence","volume":"12","author":"Ho","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.adro.2026.102178_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2011.03.002","article-title":"Radiation-induced hypothyroidism in head and neck cancer patients: A systematic review","volume":"99","author":"Boomsma","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102178_bib0004","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/j.clon.2016.05.004","article-title":"Dosimetric predictors of hypothyroidism after radical intensity-modulated radiation therapy for non-metastatic nasopharyngeal carcinoma","volume":"28","author":"Lee","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.adro.2026.102178_bib0005","first-page":"83","article-title":"Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review","volume":"33","author":"Chow","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102178_bib0006","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2022.10.034","article-title":"Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose-volume constraints with long-term endocrine outcomes","volume":"177","author":"Chow","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102178_bib0007","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jrr\/rrad091","article-title":"A multivariable normal tissue complication probability model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients in the modern radiotherapy era","volume":"65","author":"Wongwattananard","year":"2024","journal-title":"J Radiat Res"},{"key":"10.1016\/j.adro.2026.102178_bib0008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","article-title":"International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma","volume":"126","author":"Lee","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102178_bib0009","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines","volume":"110","author":"Gr\u00e9goire","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102178_bib0010","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijrobp.2017.11.004","article-title":"Delineation of neck clinical target volume specific to nasopharyngeal carcinoma based on lymph node distribution and the international consensus guidelines","volume":"100","author":"Lin","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102178_bib0011","doi-asserted-by":"crossref","first-page":"26980","DOI":"10.18632\/oncotarget.23723","article-title":"Optimization of cervical lymph node clinical target volume delineation in nasopharyngeal carcinoma: A single center experience and recommendation","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.adro.2026.102178_bib0012","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1016\/S1470-2045(25)00327-4","article-title":"Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas","volume":"26","author":"Tang","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102178_bib0013","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2025.05.019","article-title":"International consensus guideline on delineation of the clinical target volumes at different dose levels for nasopharyngeal carcinoma (2024 version)","volume":"123","author":"Lin","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102178_bib0014","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","article-title":"International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma","volume":"105","author":"Lee","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102178_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2026.06.3077","article-title":"Multicenter external validation of normal tissue complication probability models for radiation-induced primary hypothyroidism in head and neck cancer survivors with long-term endocrine outcomes","author":"Chow","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102178_bib0016","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ijrobp.2009.04.087","article-title":"NTCP modeling of subacute\/late laryngeal edema scored by fiberoptic examination","volume":"75","author":"Rancati","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102178_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110713","article-title":"Reducing radiation-induced hypothyroidism by modified delineation of cervical lymphatic drainage area for nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: 3 years\u2019 experience","volume":"204","author":"Lu","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102178_bib0018","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3390\/cancers14122993","article-title":"Change in voice quality after radiotherapy for early glottic cancer","volume":"14","author":"Meki\u0161","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.adro.2026.102178_bib0019","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clon.2013.08.006","article-title":"Dosimetric predictors of dysphonia after intensity-modulated radiotherapy for oropharyngeal carcinoma","volume":"26","author":"Sanguineti","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.adro.2026.102178_bib0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.meddos.2013.09.004","article-title":"Dosimetric difference amongst 3 techniques: TomoTherapy, sliding-window intensity-modulated radiotherapy (IMRT), and RapidArc radiotherapy in the treatment of late-stage nasopharyngeal carcinoma (NPC)","volume":"39","author":"Lee","year":"2014","journal-title":"Med Dosim"},{"key":"10.1016\/j.adro.2026.102178_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.764946","article-title":"Dosimetric comparison of helical tomotherapy, volume-modulated arc therapy, and fixed-field intensity-modulated radiation therapy in locally advanced nasopharyngeal carcinoma","volume":"11","author":"Lu","year":"2021","journal-title":"Front Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426001843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426001843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:30:39Z","timestamp":1789821039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109426001843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2452109426001843"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2026.102178","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Updated Level IVa Nodal Delineation on Thyroid Dose and Hypothyroidism Risk in Nasopharyngeal Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2026.102178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102178"}}